Imricor Medical Systems, Inc.ASX: IMR

1H 2026 Investor Presentation

· Issued by Imricor Medical Systems, Inc. via ASX

Filed with ASX · · 28 pages · English

Summary by 6ix AI

The presentation discusses regulatory progress, including FDA clearances and clinical trial updates, emphasizing the company's advancements in cardiac imaging technology. It also highlights the company's financial performance, including cash balances and operating expenses, while projecting future growth in the catheter ablation market.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) Imricor's vision is to bring iMR to every cardiac centre in the world WWW.IMRICOR.COM 1H 2026 Investor Presentation 1 August 10 th 2026 Disclaimer WWW.IMRICOR.COM IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) 2 The material contained in this ...

Imricor Medical Systems, Inc. on 6ix

In the deck

Earlier from Imricor Medical Systems

Later from Imricor Medical Systems

All Imricor Medical Systems news releases